Cargando…

Mitochondrial DNA mutations in Parkinson's disease brain

Detalles Bibliográficos
Autores principales:	Simon, David K., Matott, Joanne Clark, Espinosa, Janaina, Abraham, Neeta A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410101/ https://www.ncbi.nlm.nih.gov/pubmed/28454551 http://dx.doi.org/10.1186/s40478-017-0433-9

Ejemplares similares

Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
por: Clark, Joanne, et al.
Publicado: (2011)

MFN2 mutations cause compensatory mitochondrial DNA proliferation
por: Sitarz, Kamil S., et al.
Publicado: (2012)

Dysregulation of autophagy and mitochondrial function in Parkinson’s disease
por: Wang, Bao, et al.
Publicado: (2016)

Small-fiber neuropathy and the 3243A>G mutation in mitochondrial DNA
por: Henning, F., et al.
Publicado: (2007)

Reply: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
por: Mencacci, Niccolo E., et al.
Publicado: (2015)

Anesthetic management of a case of neurodegeneration brain iron accumulation (Hallervorden–Spatz disease)
por: Kumar, Rajender, et al.
Publicado: (2018)

Subthalamic Deep Brain Stimulation for Parkinson’s Disease—An Unexpected Encounter in the Lead Trajectory
por: Vijayaraghavan, Asish, et al.
Publicado: (2023)

New pathogenic variations of mitochondrial DNA in Alzheimer disease!!
por: Nia, Samira Sheibani, et al.
Publicado: (2013)

Both mitochondrial DNA and mitonuclear gene mutations cause hearing loss through cochlear dysfunction
por: Kullar, Peter J., et al.
Publicado: (2016)

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
por: Gaare, Johannes J, et al.
Publicado: (2018)

TNR Gene Mutation in Familial Parkinson’s Disease: Possible Implications for Essential Tremor
por: Sáenz-Farret, Michel, et al.
Publicado: (2021)

Against the traffic: The first evidence for mitochondrial DNA transfer into the plastid genome
por: Iorizzo, Massimo, et al.
Publicado: (2012)

World Brain Day 2020: Move together to end Parkinson's disease
por: Wijeratne, Tissa, et al.
Publicado: (2020)

X linked Infantile Epileptic Encephalopathy due to SMC1A Truncating Mutation
por: Naik, Neeta Ajit, et al.
Publicado: (2021)

Comparison of Pre-Deep Brain Stimulation Clinical Profiles of Patients with Young and Late-Onset Parkinson's Disease
por: Muthukumaran, P, et al.
Publicado: (2022)

Pregnancy in Parkinson's disease with PARK2 mutations()()
por: Sazci, Ali, et al.
Publicado: (2019)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Parkinsonism, Olivary Hypertrophy and Cerebellar Atrophy with TTC19 Gene Mutation
por: Mahale, Rohan R., et al.
Publicado: (2021)

Advanced Mitochondrial DNA Assay for Metabolic Syndrome
por: Sohn, Joon Hyung
Publicado: (2016)

Mitochondrial cardioencephalopathy due to a COQ4 mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Gustatory Dysfunction in Patients with Parkinson’s Disease
por: Jacob, Navya J., et al.
Publicado: (2023)

Bentall Procedure in a Patient with Parkinson Disease
por: Sreedhar, Nanditha, et al.
Publicado: (2017)

The Frequency of Korean Patients With Parkinson’s Disease Carrying GBA Mutations in a Subgroup With Age at Onset ≤ 55 Years Old
por: Hwangbo, Jin, et al.
Publicado: (2023)

Parkinsonism- Hyperpyrexia Syndrome (PHS) Crisis following Deep Brain Stimulator Battery Depletion
por: Rai, Neha, et al.
Publicado: (2023)

Neuropathy in Parkinson's Disease. Comment: Neuropathy in Parkinson's Disease: Risk Determinants and Impact on Quality of Life
por: Fustes, Otto J. H., et al.
Publicado: (2022)

Mitochondrial Ophthalmoplegia Is Not Only due to mtDNA Deletions
por: Finsterer, Josef
Publicado: (2019)

Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”
por: Finsterer, Josef, et al.
Publicado: (2018)

Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
por: Desjardins, Clément, et al.
Publicado: (2023)

Rapidly Progressive Parkinsonism and Dementia with No Insomnia due to the PRNP D178N Mutation
por: Park, Kye Won, et al.
Publicado: (2021)

Abnormal Cerebrovascular Reactivity in Parkinson's Disease
por: Prakash, Kiran
Publicado: (2015)

Parkinson's disease and obstructive sleep apnea
por: Kawada, Tomoyuki
Publicado: (2021)

Neonatal pulmonary hypertension in mitochondrial disorders due to TMEM70 mutations
por: Finsterer, Josef, et al.
Publicado: (2014)

Response to: Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”
por: Sobenin, Igor A., et al.
Publicado: (2018)

Peak-Dose Ballism Associated with Declining Implantable Pulse Generator Battery Life in Deep Brain Stimulation for Parkinson’s Disease
por: Jen-Rei, Denzel Chong, et al.
Publicado: (2021)

Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutation
por: Mattman, Andre, et al.
Publicado: (2022)

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease
por: Simon, David K, et al.
Publicado: (2010)

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
por: Bliederhaeuser, Corinna, et al.
Publicado: (2016)

Letter Regarding the Article Entitled: “The Effect of Dual Tasking and Deep Brain Stimulation Frequency Parameters on Gait in Advanced Parkinson's Disease”
por: Onder, Halil, et al.
Publicado: (2022)

Early diagnosis of brain metastases using cerebrospinal fluid cell‐free DNA‐based breakpoint motif and mutational features in lung cancer
por: Qin, Xueting, et al.
Publicado: (2023)

Novel attributes of cell‐free plasma mitochondrial DNA in traumatic injury
por: Daly, Grant T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6eep1spancsarftqc0popfruv